Search Results - "Jensen, B Vittrup" :: K.UTB vyhledávací portál

Combined doxorubicin and paclitaxel in advanced breast cancer: Effective and cardiotoxic

by Gehl, J., Boesgaard, M., Paaske, T., Jensen, B. Vittrup, Dombernowsky, P.
Published in Annals of oncology (01.09.1996)

Get full text

Journal Article

Loading…

Oral administration of irinotecan in patients with solid tumors: an open-label, phase I, dose escalating study evaluating safety, tolerability and pharmacokinetics

by Kümler, I., Sørensen, P. Grundtvig, Palshof, J., Høgdall, E., Skovrider-Ruminski, W., Theile, S., Fullerton, A., Nielsen, P. G., Jensen, B. Vittrup, Nielsen, D. L.
Published in Cancer chemotherapy and pharmacology (01.01.2019)

Get full text

Journal Article

Loading…

High circulating miR-1247 is a marker for poor prognosis in patients with metastatic colorectal cancer treated with chemotherapy and cetuximab

by Schou, J.V., Sztupinszki, Z., Johansen, J.S., Nielsen, D.L., Glimelius, B., Qvortrup, C., Sorbye, H., Jensen, B Vittrup, Pfeiffer, P.
Published in Annals of oncology (01.10.2019)

Get full text

Journal Article

Loading…

624P - High circulating miR-1247 is a marker for poor prognosis in patients with metastatic colorectal cancer treated with chemotherapy and cetuximab

by Schou, J.V., Sztupinszki, Z., Johansen, J.S., Nielsen, D.L., Glimelius, B., Qvortrup, C., Sorbye, H., Jensen, B Vittrup, Pfeiffer, P.
Published in Annals of oncology (01.10.2019)

Get full text

Journal Article

Loading…

LBA7 Pembrolizumab versus chemotherapy in microsatellite instability-high (MSI-H)/mismatch repair-deficient (dMMR) metastatic colorectal cancer (mCRC): 5-year follow-up of the KEYNOTE-177 study Asia subgroup

by Yoshino, T., André, T., Kim, T.W., Yong, W.P., Shiu, K-K., Vittrup Jensen, B., Jensen, L.H., Punt, C.J.A., Smith, D., Garcia-Carbonero, R., Alcaide-Garcia, J., Gibbs, P., de la Fouchardiere, C., Rivera, F., Elez Fernandez, M.E., Le, D.T., Zuo, Y., Fogelman, D., Adelberg, D.E., Diaz, L.
Published in Annals of oncology (01.11.2023)

Get full text

Journal Article

Loading…

LBA32 Pembrolizumab versus chemotherapy in microsatellite instability-high (MSI-H)/mismatch repair-deficient (dMMR) metastatic colorectal cancer (mCRC): 5-year follow-up of the randomized phase III KEYNOTE-177 study

by Shiu, K-K., André, T., Kim, T.W., Vittrup Jensen, B., Jensen, L.H., Punt, C.J.A., Smith, D., Garcia-Carbonero, R., Alcaide-Garcia, J., Gibbs, P., de la Fouchardiere, C., Rivera, F., Elez Fernandez, M.E., Le, D.T., Yoshino, T., Zuo, Y., Fogelman, D., Adelberg, D.E., Diaz, L.A.
Published in Annals of oncology (01.10.2023)

Get full text

Journal Article

Loading…

PACTO: A single center, randomized, phase II study of the combination of nab-paclitaxel and gemcitabine with or without tocilizumab, an IL-6R inhibitor, as first-line treatment in patients with locally advanced or metastatic pancreatic cancer

by Chen, I., Johansen, J.S., Zimmers, T.A., Dehlendorff, C., Kirk Parner, V., Vittrup Jensen, B., Nielsen, D.
Published in Annals of oncology (01.09.2017)

Get full text

Journal Article

Loading…

624PHigh circulating miR-1247 is a marker for poor prognosis in patients with metastatic colorectal cancer treated with chemotherapy and cetuximab

by Schou, J V, Sztupinszki, Z, Johansen, J S, Nielsen, D L, Glimelius, B, Qvortrup, C, Sorbye, H, Jensen, B Vittrup, Pfeiffer, P
Published in Annals of oncology (01.10.2019)

Get full text

Journal Article

Loading…

Circulating cell-free DNA as predictor of treatment failure after neoadjuvant chemoradiotherapy before surgery in patients with locally advanced rectal cancer

by Schou, J.V., Sørensen, B.S., Larsen, F.O., Abrantes, R., Boysen, A., Johansen, J.S., Vittrup Jensen, B., Nielsen, D., Spindler, K-L.
Published in Annals of oncology (01.09.2017)

Get full text

Journal Article

Loading…

699P - Pre-treatment serum 25-hydroxyvitamin D levels and survival in a Danish cohort of patients with pancreatic cancer

by Rasmussen, L.S., Yilmaz, M., Falkmer, U.G., Poulsen, L Ø, Bojesen, S.E., Vittrup Jensen, B., Johansen, A.Z., Chen, I.M., Hansen, C.P., Hasselby, J.P., Pfeiffer, P., Bjerregaard, J.K., Nielsen, S.E., Andersen, F.Z., Holländer, N.H., Bøgsted, M., Johansen, J.S.
Published in Annals of oncology (01.10.2019)

Get full text

Journal Article

Loading…

Pre-treatment serum 25-hydroxyvitamin D levels and survival in a Danish cohort of patients with pancreatic cancer

by Rasmussen, L.S., Yilmaz, M., Falkmer, U.G., Poulsen, L Ø, Bojesen, S.E., Vittrup Jensen, B., Johansen, A.Z., Chen, I.M., Hansen, C.P., Hasselby, J.P., Pfeiffer, P., Bjerregaard, J.K., Nielsen, S.E., Andersen, F.Z., Holländer, N.H., Bøgsted, M., Johansen, J.S.
Published in Annals of oncology (01.10.2019)

Get full text

Journal Article

Loading…

112P Pembrolizumab vs chemotherapy in patients with microsatellite instability-high/mismatch repair deficient metastatic colorectal cancer: Asia subgroup results of the phase III KEYNOTE-177 study

by Yoshino, T., Kim, T.W., Yong, W.P., Shiu, K-K., Jensen, B. Vittrup, Jensen, L. Henrik, Smith, D., Garcia-Carbonero, R., Alcaide-Garcia, J., Gibbs, P., Fouchardiere, C. de la, Rivera, F., Elez, E., Bendell, J., Le, D.T., Yang, P., Farooqui, M., Marinello, P., Diaz, L.A., Andre, T.
Published in Annals of oncology (01.11.2020)

Get full text

Journal Article

Loading…

699PPre-treatment serum 25-hydroxyvitamin D levels and survival in a Danish cohort of patients with pancreatic cancer

by Rasmussen, L S, Yilmaz, M, Falkmer, U G, Poulsen, L Ø, Bojesen, S E, Vittrup Jensen, B, Johansen, A Z, Chen, I M, Hansen, C P, Hasselby, J P, Pfeiffer, P, Bjerregaard, J K, Nielsen, S E, Andersen, F Z, Holländer, N H, Bøgsted, M, Johansen, J S
Published in Annals of oncology (01.10.2019)

Get full text

Journal Article